Suja Life has lowered its forecasts for annual sales and earnings, pointing to “current macroeconomic conditions and continued softness in the grocery channel”.
The US juices and shots producer expects full-year net sales to reach $351-$354m, representing year-on-year growth of 7.5% to 8.4%.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Californian business had projected sales of $360-$369m, itself down from a $367-$371m forecast issued in June.
Suja Life is estimating its adjusted EBITDA will reach $68-$70m in 2026, reflecting an increase of 67.9% to 72.8% but down from its previous forecast of $70-$72m.
CEO Maria Stipp said the company had “continued to gain share of natural healthy beverage in the third quarter while most of the category’s largest players lost share”.
She added: “Even with continued pressure in grocery, we’re winning where shoppers are going, our newer lines are leading the way, and we expect adjusted EBITDA to grow roughly 70% this year, with margin expanding to nearly 20%, while investing deliberately behind our brands.
“With only about 11% of US households buying our brands today, we see significant room to grow over the long term.”
Suja Life is majority-owned by private-equity firm Paine Schwartz Partners. Its portfolio comprises Suja Organic juices and shots, Vive Organic shots and Slice sodas.
Stipp added: “We’re concentrating our investment on the brands, channels and programmes with the potential of delivering the clearest returns, and we believe this positions Suja for more consistent, profitable growth over time.”
In the three months ended 28 September, Suja Life saw net sales rise 3.3% to $76.4m.
Its loss from operations narrowed to $3m from $7.1m, while its net losses improved to $8.3m against $14.6m in the third quarter of 2025.
For the first nine months of the fiscal year, net sales increased 13% to $267.3m.
However, the group swung to a nine-month operating loss of $7.2m, down from an operating profit of $2.2m a year earlier, weighed down by $25.1m in costs related to its stock-market listing in May.
Similarly, its net losses widened to $28.4m from $21.1m in the first nine months of 2025.
